These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1661588)

  • 41. Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable.
    Furlong RA; Takehara T; Taylor WG; Nakamura T; Rubin JS
    J Cell Sci; 1991 Sep; 100 ( Pt 1)():173-7. PubMed ID: 1839027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein.
    Shima N; Nagao M; Ogaki F; Tsuda E; Murakami A; Higashio K
    Biochem Biophys Res Commun; 1991 Oct; 180(2):1151-8. PubMed ID: 1835383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
    J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of scatter factor and hepatocyte growth factor on motility and morphology of MDCK cells.
    Li Y; Joseph A; Bhargava MM; Rosen EM; Nakamura T; Goldberg I
    In Vitro Cell Dev Biol; 1992 May; 28A(5):364-8. PubMed ID: 1534555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues.
    Tashiro K; Hagiya M; Nishizawa T; Seki T; Shimonishi M; Shimizu S; Nakamura T
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3200-4. PubMed ID: 2139229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional activity of hepatocyte nuclear factor-1 is specifically decreased in amino acid-limited hepatoma cells.
    Marten NW; Hsiang CH; Yu L; Stollenwerk NS; Straus DS
    Biochim Biophys Acta; 1999 Oct; 1447(2-3):160-74. PubMed ID: 10542313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genomic organization, chromosomal localization and developmental expression of hepatocyte growth factor-like protein.
    Han S; Degen SJ
    EXS; 1993; 65():81-105. PubMed ID: 8422550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purification and characterization of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats.
    Asami O; Ihara I; Shimidzu N; Shimizu S; Tomita Y; Ichihara A; Nakamura T
    J Biochem; 1991 Jan; 109(1):8-13. PubMed ID: 1826679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant kringle 5 from plasminogen antagonises hepatocyte growth factor-mediated signalling.
    Ansell PJ; Zhang H; Davidson DJ; Harlan JE; Xue J; Brodjian S; Lesniewski R; McKeegan E
    Eur J Cancer; 2010 Mar; 46(5):966-73. PubMed ID: 20061137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering.
    Tanimura S; Chatani Y; Hoshino R; Sato M; Watanabe S; Kataoka T; Nakamura T; Kohno M
    Oncogene; 1998 Jul; 17(1):57-65. PubMed ID: 9671314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells.
    De Lédinghen V; Monvoisin A; Neaud V; Krisa S; Payrastre B; Bedin C; Desmoulière A; Bioulac-Sage P; Rosenbaum J
    Int J Oncol; 2001 Jul; 19(1):83-8. PubMed ID: 11408926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase C.
    Shiota G; Kawasaki H; Nakamura T; Schmidt EV
    Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):271-8. PubMed ID: 7827802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the effects of human placental HGF on rat hepatocytes.
    Hernandez J; Zarnegar R; Michalopoulos GK
    J Cell Physiol; 1992 Jan; 150(1):116-21. PubMed ID: 1370501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation.
    Gal-Levi R; Leshem Y; Aoki S; Nakamura T; Halevy O
    Biochim Biophys Acta; 1998 Mar; 1402(1):39-51. PubMed ID: 9551084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocyte growth factor is a potent promoter of mitogenesis in cultured rat visceral glomerular epithelial cells.
    Kawaguchi M; Kawashima F; Ohshima K; Kawaguchi S; Wada H
    Cell Mol Biol (Noisy-le-grand); 1994 Dec; 40(8):1103-11. PubMed ID: 7873982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel herbal formulation "LiverCare" differentially regulates primary rat hepatocyte and hepatocarcinoma cell proliferation in vitro.
    Vidyashankar S; Varma SR; Azeemudin M; Godavarthi A; Krishna NS; Patki PS
    J Med Food; 2011 Sep; 14(9):1023-31. PubMed ID: 21812649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes.
    Auer KL; Contessa J; Brenz-Verca S; Pirola L; Rusconi S; Cooper G; Abo A; Wymann MP; Davis RJ; Birrer M; Dent P
    Mol Biol Cell; 1998 Mar; 9(3):561-73. PubMed ID: 9487126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
    Hashimoto T; Kato M; Shimomura T; Kitamura N
    FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.
    Montesano R; Soriano JV; Malinda KM; Ponce ML; Bafico A; Kleinman HK; Bottaro DP; Aaronson SA
    Cell Growth Differ; 1998 May; 9(5):355-65. PubMed ID: 9607557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.